Skip to NavigationSkip to content

News

Novartis lands itself in hot water over questionable deal with Trump's lawyer, while UK MPs demand UK pharma be aligned with EU operations post-...
The Ebola outbreak in the Democratic Republic of Congo is becoming increasingly serious, after it was confirmed that there was a case of a person...
Pfizer has revealed new Phase 3 data for its oral epilepsy therapy Lyrica (pregbalin) as an adjunctive treatment for partial onset seizures...
The first in a new class of migraine treatments has just received approval from the FDA; Amgen and Novartis’ Aimovig is the first CGRP inhibitor to...
A team of researchers from the University of Cambridge and Warwick Clinical Trials have revealed that Roche’s Herceptin is just as effective after a...
Amgen has revealed that its PCSK9 inhibitor Repatha (evolocumab) has received approval from the European Commission in a new indication: to reduce...
Ipsen has revealed that it has received approval for the use of Cabometyx for first-line use in patients with advanced renal cell carcinoma.
The FDA has made an important leap in combatting the US opioid crisis with the approval of Lucemyra (lofexidine hydrochloride) for managing the...
A new report published by the Business, Energy and Industrial Strategy Committee has called for the UK government to ensure that the pharmaceutical...
NICE has announced that Roche's Tecentriq will be made available for patients with advanced bladder cancer as a second-line treatment.
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches